Volume 23, Number 7—July 2017
Research Letter
Haemophilus influenzae Type a Meningitis in Immunocompetent Child, Oman, 2015
Kiran P. Sawardekar
Table
Results of sequential laboratory tests and CT scans of the head during the clinical course of Hia meningitis in a child admitted to Nizwa Hospital, Oman, August 2015*
| Test type |
Hospitalization day |
||||||||
| 1 |
2 |
8 |
10 |
14 |
18 |
26 |
27 |
||
| Adm |
Adm + 12 |
||||||||
| Blood | |||||||||
| Leukocytes, × 103 cells/μL† | 2.24 | 8.71 | 10.52 | 13.08 | 12.32 | 8.48 | 4.56 | ||
| Neutrophils, × 103 cells/μL‡ | 0.78 | 6.04 | 7.66 | 4.92 | 5.51 | 2.50 | 0.82 | ||
| Lymphocytes, × 103 cells/μL§ | 1.22 | 2.02 | 2.38 | 5.98 | 5.21 | 5.12 | 2.89 | ||
| Platelets, × 103/μL¶ | 158.30 | 79.12 | 41.13 | 419.90 | 644.70 | 525.80 | 279.20 | ||
| Hemoglobin, g/dL# | 10.18 | 9.30 | 9.13 | 9.06 | 8.47 | 9.22 | 10.38 | ||
| CRP, mg/L** | 79.30 | 483.40 | 248.50 | 33.70 | 35.30 | ||||
| Blood culture |
Hia |
NG |
NG |
||||||
| CSF | |||||||||
| Leukocytes, cells/mm3 | 2,970 | 390 | 65 | ||||||
| Neutrophils, % | 91 | 10 | 12 | ||||||
| Lymphocytes, % | 9 | 90 | 88 | ||||||
| Protein, mg/dL†† | 190.79 | 100.34 | 27.11 | ||||||
| Glucose, mmol/L‡‡ | 1.13 | 2.24 | 2.83 | ||||||
| Glucose CSF:blood | 0.26 | 0.56 | 0.70 | ||||||
| Gram stain | NM | NM | NM | ||||||
| Culture |
NG |
NG |
NG |
||||||
| CT scan of the head | |||||||||
| Unremarkable | Mild ventricular dilation with bilateral subdural effusion | Complete disappearance of subdural effusion; persistence of mild ventricular dilation | |||||||
*Adm, at admission; Adm + 12, 12 h after admission; CRP, C-reactive protein; CSF, cerebrospinal fluid; CT, computed tomography; Hia, Haemophilus Influenzae type a; NA, not applicable; NG, no growth; NM, no microorganisms.
†Reference range 4.5–14.5 × 103 cells/μL.
‡Reference range 1.4–9.0 × 103 cells/μL.
§Reference range 1.9–9.8 × 103 cells/μL.
¶Reference range 150–450 × 103/μL.
#Reference range 11.5–15.5 g/dL.
**Reference range 0–5 mg/L.
††Reference range 15–45 mg/dL.
‡‡Reference range 2.2–3.9 mmol/L.
Page created: June 19, 2017
Page updated: June 19, 2017
Page reviewed: June 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.